TY - JOUR
T1 - Adherence of patients with type 2 diabetes mellitus to medications
T2 - the role of risk preferences
AU - Simon-Tuval, Tzahit
AU - Shmueli, Amir
AU - Harman-Boehm, Ilana
N1 - Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Objective: To examine whether risk tolerance is associated with adherence to oral hypoglycemic agents (OHAs). Methods: We performed a cross-sectional study among adult patients with type 2 diabetes mellitus (n = 308) presenting for routine out-patient visits, using validated questionnaires to estimate: risk preferences (risk-seeking, risk averse, risk neutral), motivation, self-efficacy, impulsivity, perception of the disease and of the interpersonal process of care, demographic and socioeconomic characteristics; computerized patient medical records to estimate disease severity and a computerized database for retrieval of medication adherence, 1 year before the interview. Adherence was estimated using prescription-based measures of proportion of days covered (PDC). Concurrent adherence was calculated as: PDC with ≥1 OHAs; average PDC; PDC of ≥80% for all OHAs. Results: Multivariable ordered logit model revealed that compared to others, risk-seeking patients had lower PDC with ≥1 OHAs (β = −0.50, p ≤.1). Specifically, risk-seeking patients were 11.2 percentage points less likely to have ≥80% of the follow-up period covered with ≥1 OHAs available (p ≤.1). In addition, risk-seeking patients had lower average PDC (β = −0.85, p ≤.05). Specifically, these patients were 19.5 percentage points less likely to have an average PDC of ≥80% (p ≤.05). Multivariable logistic model revealed that risk-seeking was associated with lower probability of having PDC ≥80% for all OHAs in the follow-up period (OR; 90% CI: 0.59; 0.35–0.97). Conclusions: Risk-seeking patients are less adherent to OHA medications. Identifying these patients may enable practitioners to proactively tailor strategies to improve their adherence and health outcomes.
AB - Objective: To examine whether risk tolerance is associated with adherence to oral hypoglycemic agents (OHAs). Methods: We performed a cross-sectional study among adult patients with type 2 diabetes mellitus (n = 308) presenting for routine out-patient visits, using validated questionnaires to estimate: risk preferences (risk-seeking, risk averse, risk neutral), motivation, self-efficacy, impulsivity, perception of the disease and of the interpersonal process of care, demographic and socioeconomic characteristics; computerized patient medical records to estimate disease severity and a computerized database for retrieval of medication adherence, 1 year before the interview. Adherence was estimated using prescription-based measures of proportion of days covered (PDC). Concurrent adherence was calculated as: PDC with ≥1 OHAs; average PDC; PDC of ≥80% for all OHAs. Results: Multivariable ordered logit model revealed that compared to others, risk-seeking patients had lower PDC with ≥1 OHAs (β = −0.50, p ≤.1). Specifically, risk-seeking patients were 11.2 percentage points less likely to have ≥80% of the follow-up period covered with ≥1 OHAs available (p ≤.1). In addition, risk-seeking patients had lower average PDC (β = −0.85, p ≤.05). Specifically, these patients were 19.5 percentage points less likely to have an average PDC of ≥80% (p ≤.05). Multivariable logistic model revealed that risk-seeking was associated with lower probability of having PDC ≥80% for all OHAs in the follow-up period (OR; 90% CI: 0.59; 0.35–0.97). Conclusions: Risk-seeking patients are less adherent to OHA medications. Identifying these patients may enable practitioners to proactively tailor strategies to improve their adherence and health outcomes.
KW - adherence
KW - Diabetes
KW - medication
KW - risk preferences
UR - http://www.scopus.com/inward/record.url?scp=85034650324&partnerID=8YFLogxK
U2 - 10.1080/03007995.2017.1397506
DO - 10.1080/03007995.2017.1397506
M3 - Article
C2 - 29069921
AN - SCOPUS:85034650324
SN - 0300-7995
VL - 34
SP - 345
EP - 351
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
IS - 2
ER -